x
CME-Tagline

As We Age: Considering the Impact of Renal Impairment When Choosing an HIV Pre-Exposure Prophylaxis (PrEP) Formulation

CMEO Webcast

Premiere Date: Thursday, September 30, 2021

This activity offers CE credit for:

  1. ABIM (MOC)
  2. Medicine (accme)
  3. Nursing (ANCC)
  4. Pharmacy (acpe)
  5. PA (aapa)
  6. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Friday, September 30, 2022

Faculty


Christine Heumann, MD, MPH Christine Heumann, MD, MPH 
Assistant Professor of Clinical Medicine
Department of Medicine, Division of Infectious Diseases
Indiana University School of Medicine
Medical Director, Bell Flower Clinic & STD Control Program
Marion County Public Health Department
Indianapolis, IN

Statement of Need

Lack of knowledge about PrEP remains a major barrier for optimal PrEP uptake. Furthermore, knowledge of PrEP and long-term risk mitigation related to renal impairment and use in individuals with medical comorbidities is necessary for improving widespread uptake. This is particularly important in aging individuals who are at risk for contracting HIV, as they may have medical comorbidities and risk factors that will impact treatment decisions.

This CME Outfitters BriefCase will introduce Matthew, a 53-year-old Hispanic man who has type 2 diabetes and hypertension who originally dismissed HIV prevention strategies but after considering the risk and consequences of HIV infection is now open to discussion. This patient case will be used to highlight how best to engage older adults who are at risk for contracting HIV in discussions about HIV prevention strategies, including assessing and applying clinical trial data to decision-making for PrEP initiation.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Apply clinical trial data and other available evidence to decision making for initiation of PrEP.

Financial Support

Supported by an educational grant from Gilead Sciences, Inc.

Target Audience

Physicians, PAs, nurse practitioners, nurses, and pharmacists

Credit Information

ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning format: Enduring material

Royal College MOC:Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Heumann reports that she receives research support as site principal investigator for Gilead Sciences, Inc. Purpose 2 study (GS-US-528-9023).

Michael Franks, APRN, AGACNP-BC, FNP-BC, (peer reviewer) has no disclosures to report.

Mae Ochoa, RPh, (peer reviewer) has no disclosures to report.

Susan Perry (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC, staff: No disclosures to report.

CME Outfitters, LLC, and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


This document was last modified on:

BC-056-093021-47